Analytical Data
-
Gene name
NTAL
- Application
-
Alternative Names
WBSCR15, WBSCR5; WSCR5, HSPC046, LAB, NTAL; Williams-Beuren Syndrome Chromosome Region 5; Linker For Activation Of B Cells; Non-T Cell Activation Linker
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q9GZY6
-
Expression Region
Arg30~Met209
-
Molecular Weight
24kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NTAL, or Non-T Cell Activation Linker, is a membrane-associated protein predominantly expressed in hematopoietic cells, playing a crucial role in modulating immune responses. Research into NTAL has gained momentum due to its involvement in various signaling pathways, particularly those governing lymphocyte activation and development. Emerging studies suggest that NTAL may regulate key processes such as cell survival, proliferation, and differentiation, making it a significant player in both adaptive and innate immunity. The study of NTAL as a recombinant protein has opened new avenues for understanding its structural and functional properties, providing insight into its role in immune dysregulation and potential implications for autoimmune diseases and malignancies. Given its critical functions, NTAL is also being explored as a biomarker for disease progression and a target for therapeutic interventions. The ongoing investigations into NTAL offer promising prospects for novel immunotherapies and a deeper comprehension of the intricate network underlying immune system dynamics.
